** Shares in Synlab SYAB.DE fall around 6% in early
Frankfurt trade after the German laboratory services group's
profit missed expectations
** "Q3 revenues were in line, but adj EBITDA came in 5.6%
below" J.P.Morgan says
** JPM notes the company's 2023 guidance suggests about 3%
upside to revenues, but lower margins as the COVID-19 revenues
decrease and cost inflation continues to be a headwind
** "Old medium-term outlook has looked for 21-23% margin but
was already questioned by company and capital market," a local
trader says, adding the company's EBITDA missed expectations
with 135 mln euros vs. 148 mln euros expected
** The stock is at the bottom of Germany's small-cap
index .SDAXI
($1 = 0.9994 euros)
(Reporting by Ozan Ergenay)
((ozan.ergenay@thomsonreuters.com))